Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease
Authors
Keywords
-
Journal
npj Parkinsons Disease
Volume 8, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-11-12
DOI
10.1038/s41531-022-00384-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synergistic Association between Plasma Aβ1–42 and p-tau in Alzheimer’s Disease but Not in Parkinson’s Disease or Frontotemporal Dementia
- (2021) Ming-Jang Chiu et al. ACS Chemical Neuroscience
- Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease
- (2021) Whitley W. Aamodt et al. MOVEMENT DISORDERS
- A multicentre validation study of the diagnostic value of plasma neurofilament light
- (2021) Nicholas J. Ashton et al. Nature Communications
- Temporal trajectory of biofluid markers in Parkinson’s disease
- (2021) Min Seok Baek et al. Scientific Reports
- Parkinson disease-associated cognitive impairment
- (2021) Dag Aarsland et al. Nature Reviews Disease Primers
- Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies
- (2021) Maria C. Gonzalez et al. JAMA Neurology
- Blood Neurofilament Light Chain in Parkinson’s Disease: Comparability between Parkinson’s Progression Markers Initiative (PPMI) and Asian Cohorts
- (2021) Jia-Hung Chen et al. Journal of Clinical Medicine
- Neurofilament light chain and α-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes
- (2021) Corinne Quadalti et al. npj Parkinsons Disease
- Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration
- (2020) Elisabeth H. Thijssen et al. NATURE MEDICINE
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
- (2020) Thomas K Karikari et al. LANCET NEUROLOGY
- CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories
- (2020) Stefanie Lerche et al. MOVEMENT DISORDERS
- An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders
- (2020) Nicholas J. Ashton et al. Nature Reviews Neurology
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders
- (2020) Sebastian Palmqvist et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- NfL as a biomarker for neurodegeneration and survival in Parkinson disease
- (2020) David Bäckström et al. NEUROLOGY
- The Non‐Motor Symptoms Scale in Parkinson’s disease: Validation and use
- (2020) Daniel J. van Wamelen et al. ACTA NEUROLOGICA SCANDINAVICA
- Classifications of Neurodegenerative Disorders Using a Multiplex Blood Biomarkers-Based Machine Learning Model
- (2020) Chin-Hsien Lin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Blood NfL
- (2019) Chin-Hsien Lin et al. NEUROLOGY
- Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer’s Disease
- (2018) Che-Chuan Yang et al. JOURNAL OF ALZHEIMERS DISEASE
- Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
- (2018) Chin-Hsien Lin et al. Frontiers in Aging Neuroscience
- Amyloid-β and Parkinson’s disease
- (2018) Ee Wei Lim et al. JOURNAL OF NEUROLOGY
- Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease
- (2018) Yung-Shuan Lin et al. Scientific Reports
- Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders
- (2018) Bob Olsson et al. JAMA Neurology
- Comprehensive grading of Parkinson’s disease using motor and non-motor assessments: addressing a key unmet need
- (2017) Pablo Martinez-Martin et al. Expert Review of Neurotherapeutics
- Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study
- (2017) Anette Schrag et al. LANCET NEUROLOGY
- Personalized medicine in Parkinson's disease: Time to be precise
- (2017) Nataliya Titova et al. MOVEMENT DISORDERS
- Serum neurofilament light in familial Alzheimer disease
- (2017) Philip S.J. Weston et al. NEUROLOGY
- Blood-based NfL
- (2017) Oskar Hansson et al. NEUROLOGY
- Comprehensive grading of Parkinson’s disease using motor and non-motor assessments: addressing a key unmet need
- (2017) Pablo Martinez-Martin et al. Expert Review of Neurotherapeutics
- MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study
- (2016) Roberta Biundo et al. JOURNAL OF NEURAL TRANSMISSION
- Parkinson’s: a syndrome rather than a disease?
- (2016) Nataliya Titova et al. JOURNAL OF NEURAL TRANSMISSION
- Non motor subtypes and Parkinson's disease
- (2016) Anna Sauerbier et al. PARKINSONISM & RELATED DISORDERS
- Cerebrospinal fluid tau and amyloid-β1-42in patients with dementia
- (2015) Tobias Skillbäck et al. BRAIN
- Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease
- (2015) David C. Bäckström et al. JAMA Neurology
- CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival
- (2014) T. Skillback et al. NEUROLOGY
- Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study
- (2014) C. H. Adler et al. NEUROLOGY
- The economic impact of cognitive impairment in Parkinson's disease
- (2011) Corinna Vossius et al. MOVEMENT DISORDERS
- CSF amyloid 1-42 predicts cognitive decline in Parkinson disease
- (2010) A. Siderowf et al. NEUROLOGY
- Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria
- (2009) Dennis W Dickson et al. LANCET NEUROLOGY
- International study on the psychometric attributes of the Non-Motor Symptoms Scale in Parkinson disease
- (2009) P. Martinez-Martin et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now